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Abstract
Purpose This study investigated the effect of food additives, artificial sweeteners and domestic hygiene products on the gut 
microbiome and fibre fermentation capacity.
Methods Faecal samples from 13 healthy volunteers were fermented in batch cultures with food additives (maltodextrin, 
carboxymethyl cellulose, polysorbate-80, carrageenan-kappa, cinnamaldehyde, sodium benzoate, sodium sulphite, titanium 
dioxide), sweeteners (aspartame-based sweetener, sucralose, stevia) and domestic hygiene products (toothpaste and dish-
washing detergent). Short-chain fatty acid production was measured with gas chromatography. Microbiome composition 
was characterised with 16S rRNA sequencing and quantitative polymerase chain reaction (qPCR).
Results Acetic acid increased in the presence of maltodextrin and the aspartame-based sweetener and decreased with 
dishwashing detergent or sodium sulphite. Propionic acid increased with maltodextrin, aspartame-based sweetener, sodium 
sulphite and polysorbate-80 and butyrate decreased dramatically with cinnamaldehyde and dishwashing detergent. Branched-
chain fatty acids decreased with maltodextrin, aspartame-based sweetener, cinnamaldehyde, sodium benzoate and dish-
washing detergent. Microbiome Shannon α-diversity increased with stevia and decreased with dishwashing detergent and 
cinnamaldehyde. Sucralose, cinnamaldehyde, titanium dioxide, polysorbate-80 and dishwashing detergent shifted microbi-
ome community structure; the effects were most profound with dishwashing detergent (R2 = 43.9%, p = 0.008) followed by 
cinnamaldehyde (R2 = 12.8%, p = 0.016). Addition of dishwashing detergent and cinnamaldehyde increased the abundance of 
operational taxonomic unit (OTUs) belonging to Escherichia/Shigella and Klebsiella and decreased members of Firmicutes, 
including OTUs of Faecalibacterium and Subdoligranulum. Addition of sucralose and carrageenan-kappa also increased the 
abundance of Escherichia/Shigella and sucralose, sodium sulphite and polysorbate-80 did likewise to Bilophila. Polysorb-
ate-80 decreased the abundance of OTUs of Faecalibacterium and Subdoligranulum. Similar effects were observed with 
the concentration of major bacterial groups using qPCR. In addition, maltodextrin, aspartame-based sweetener and sodium 
benzoate promoted the growth of Bifidobacterium whereas sodium sulphite, carrageenan-kappa, polysorbate-80 and dish-
washing detergent had an inhibitory effect.
Conclusions This study improves understanding of how additives might affect the gut microbiota composition and its fibre 
metabolic activity with many possible implications for human health.
Keywords Food additives · Microbiota · Fermentation capacity · Fibre · Gut microbiome
Introduction
A great amount of research has investigated the role of 
dietary nutrients, or dietary patterns in general, on the gut 
microbiome. Dietary fibre has attracted the most interest, 
mainly due to the inability of the human body to utilise it, 
and the capability of the gut microbiome to ferment it using 
a broad spectrum of enzymes not encoded in the human 
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genome cannot encode [1]. Short-chain fatty acids (SCFA) 
are the end-product of fibre fermentation and the SCFA 
produced are dependent on the host’s diet and microbiome 
composition. Species within Bacteroides produce primarily 
acetic acid and propionic acid [2, 3]; members of Clostrid-
ium leptum cluster produce butyric acid from fibre fermen-
tation and Bifidobacterium produces lactate and acetic acid 
from carbohydrate fermentation [4]. The branch chain fatty 
acids (BCFA) iso-butyric acid and iso-valeric acid are pro-
duced from protein breakdown, particularly in the absence 
of fermentable carbohydrate. Yet, the human gut microen-
vironment dynamics are more complex and characterised 
by an extensive degree of inter-species synergy and cross-
feeding. It is, therefore, important to study the interactions 
between diet and the gut microbiome in the context of the 
entire microbial community and not as microbes in isola-
tion. SCFA are critical bacterial products involved, not only 
locally in gut health, but in whole-body homeostasis. Along 
with an increased microbial diversity, high butyric acid con-
centration in the gut has been used as an indicator of healthy 
status of the microbiome. In contrast, reduced diversity, low 
luminal production of SCFA and dysbiosis have been pro-
posed as primary events of inflammatory bowel disease, 
diabetes and obesity [5–8].
Our diet has evolved enormously and rapidly over the last 
century, in parallel with food preservation and processing 
and increased use of industrialised and domestic hygiene 
products. While food industrialisation has protected human-
ity from infectious diseases, the secondary effect this may 
have on gut microbiome-dependent host health, and the net 
impact on the incidence of non-communicable diseases has 
only relatively recently been considered. A Mediterranean 
diet with increased consumption of legumes, cereals, fruit 
and vegetables, and its health-promoting effects, influences 
the gut microbiome [9]. The Western diet, which includes 
food additives and preservatives, has contrastingly been 
associated with non-communicable diseases [10]. Food 
additives and artificial sweeteners have become increasingly 
prevalent within our diet, with more than 50% of available 
food in UK households being ultra-processed [11]. While 
food additives are evaluated rigorously for their effects on 
the host, health testing of food additives fails to include their 
effect on the human gut microbiome and by proxy long-term 
host health [12]. Recent studies in animals have indicated 
that food additives can have adverse effects on colonic and 
cardiovascular health, mediated by the gut microbiome and 
changes in the gut mucus layer. It has been shown that food 
emulsifiers, such as polysorbates and carboxymethyl cellu-
lose can increase intestinal permeability, alter microbiota 
composition, promote Escherichia coli translocation across 
the epithelium and in M cells in-vitro causing gut inflam-
mation [10, 13]. Likewise, the body of evidence on artifi-
cial sweeteners indicates that there are adverse metabolic 
outcomes in rodents owing to the onset of microbial dys-
biosis [14–16]. Cumulative ingestion of residual products 
from regular use of domestic hygiene products may influ-
ence the human gut microbiome and, by extension, the 
health of the host. In epidemiological research, increased 
use of dishwashers, which reduce residual domestic deter-
gent on dishware and consequent accidental ingestion, was 
associated with a decrease in cardiovascular disease [17]. 
Although for some food additives, artificial sweeteners and 
domestic hygiene products a large amount will be digested 
or degraded in the upper part of the gastrointestinal tract, 
residual amounts can still reach the colon. Others, like car-
rageenans and carboxylmethyl cellulose will reach the colon 
in similar amounts to those ingested.
It is, therefore, important to study the effect of food addi-
tives, artificial sweeteners and domestic hygiene products 
may have on gut microbiota composition and its fibre fer-
mentation capacity, the most important bacterial function 
for host health. There is currently limited knowledge on the 
effect of additives on the human gut microbiota, and research 
to date has predominantly occurred in animal models with a 
paucity of evidence in humans. This preclinical study inves-
tigated the effect that commonly consumed food additives, 
including emulsifiers, artificial sweeteners and domestic 
hygiene products might have on the healthy human micro-
biota composition and its fibre fermentation capacity using 
in-vitro batch faecal fermentations.
Subjects and methods
Participants
Thirteen young healthy adults (females, n = 7; mean, (SD); 
age: 24.8, (2.2) years; body mass index (BMI) 21.9, (2.8) 
kg/m2) donated a single faecal sample. Participants who had 
used antibiotics within the three months prior were not eli-
gible to participate. Participants provided informed consent. 
The study received ethical approval by the Medical, Veteri-
nary and Life Sciences Research Ethics Committee, at the 
University of Glasgow.
In‑vitro batch faecal fermentation studies
Faecal samples were collected in disposable containers and 
processed within one hour of defecation. From each donor, 
a faecal slurry (16% w/v) was prepared using 16 g of fae-
cal matter homogenised in 100 ml Sorensen’s buffer pH 7, 
boiled and degassed under oxygen-free nitrogen stream. The 
faecal slurry was strained through 30-denier nylon stockings 
to remove coarse material and remained in suspension by 
continuous agitation using a magnetic stirrer. In a 150 ml 
flask, 5 ml of 16% faecal slurry were added along with 42 ml 
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of in-house prepared fermentation medium, 2 ml of reduc-
ing solution, 400 mg of fibre substrate (see below) and one 
of the additives in testing. Assuming that an average person 
has a faecal output of 120 g/day [18] and a recommended 
intake of the fibre of 30 g/day, this would be equivalent to 
roughly double the amount of fibre available for fermenta-
tion per g of faeces.
The fermentation medium was prepared in-house (1 litre). 
It consisted of 225 ml of macromineral solution (0.04 M 
 Na2HPO4, 0.046  M  KH2PO4, 0.002  M  MgSO4·7H2O), 
225 ml buffer solution (0.051 M  NH4HCO3 and 0.417 M 
 NaHCO3), 112.5 μl of micromineral solution (0.898 M 
 CaCl2·2H2O, 0.505 M  MnCl2·4H2O, 0.042 M  CoCl2·6H2O, 
and 0.296 M  FeCl3·6H2O), 1.125 ml of 0.1% resazurin solu-
tion, 450 ml of 5 mg/mL Tryptone, 100 mg of mucin from 
porcine stomach, and 76 mg of mixed bile extract from por-
cine. Once the solution was made, it was boiled, degassed 
under oxygen-free nitrogen, and adjusted to pH 7 to mimic 
the distal intestinal environment. Reducing solution (50 ml) 
was made up of 2 ml of 1 M NaOH, 312.5 mg of cysteine 
hydrochloride and 312.5 mg of  Na2S·9H2O.
The fibre substrate was made up of 100 mg of apple 
pectin (SIGMA, Pectin, from apple), 100 mg of raftilose 
(Beneo™, Orafti P95), 100 mg of α-cellulose (SIGMA™, 
α-CELLULOSE), and 100 mg of high resistant maize starch 
(National StarchTM, HI-MAIZE[TM] 260). We chose these 
fibres as indicative of food consumed in the UK diet [19].
Eight food additives [maltodextrin, carboxymethyl cellu-
lose, polysorbate-80, carrageenan-kappa, sodium benzoate, 
sodium sulphite, titanium dioxide, cinnamaldehyde], three 
artificial sweeteners [aspartame-based sweetener, sucra-
lose, stevia], and two domestic hygiene products [tooth-
paste, dishwashing detergent] were used. Test amounts 
were based on the acceptable daily intake or estimated daily 
consumption, assuming an average male adult weighing 
75 kg (Online Resource 1). Where the estimated daily con-
sumption was relatively large (maltodextrin, carboxymethyl 
cellulose, polysorbate-80, carrageenan-kappa, aspartame-
based sweetener), the amount tested was standardised to 
500 mg. Likewise, where estimated daily consumption was 
relatively small (stevia, cinnamaldehyde, sodium benzoate, 
sodium sulphite, sucralose), the amount tested was 50% of 
the acceptable daily intake. For the toothpaste and the dish-
washing detergent, the amount tested was 100% of estimated 
accidental intake (Online Resource 1). Selection of additives 
was based on previous research which implicated them in the 
onset of non-communicable diseases including inflammatory 
bowel disease and metabolic syndrome [10, 20, 21].
Thirteen fermentation flasks, one for each of the additives 
above, and a non-additive blank (hereafter referred to as con-
trol) were degassed under oxygen-free nitrogen stream and 
incubated in a shaking water bath at 37 °C at 60 strokes/min 
for 24 h. A baseline sample was collected from the control 
prior to incubation start and from all other additives and the 
control after 24 h of incubation. Aliquots of fermentation 
slurry for SCFA analysis were collected and stored in 3:1 
ratio with 1 M NaOH at − 20 °C until analysis. Fermenta-
tion slurry aliquots were stored at -80 °C and total DNA was 
extracted within a month of collection.
Measurement of net SCFA production
The SCFA (acetic acid, propionic acid, butyric acid, valeric 
acid, caproic acid, heptanoic acid, and caprylic acid) and 
BCFA (iso-butyric acid and iso-valeric acid) were extracted 
from acidified slurries three times in total using diethyl 
ether. Extracts were analysed using Gas Chromatography 
(Agilent 7890A) with flame ionisation detector, as described 
previously [22, 23]. Each of the SCFA was quantified against 
calibration curves plotted using authentic external stand-
ards [acetic acid (185.8 mM), propionic acid (144.5 mM), 
butyric acid (114.2 mM), valeric acid (83.4 mM), caproic 
acid (52.6 mM), heptanoic acid (65.8 mM), caprylic acid 
(53.2 mM), isobutyric acid (97.3 mM), and isovaleric acid 
(87.0 mM) all stored in 2 M NaOH and using 2-ethylbutyric 
acid (74.0 mM) as internal standard. All samples from the 
same participant were analysed in the same run to minimise 
inter-assay variation. Each sample was measured twice, and 
in all cases the average concentration was calculated unless 
the % co-efficient of variation was greater than 10% in which 
case a third replicate was analysed. Concentration of SCFA 
(μmol) is reported per volume (ml) of fermentation slurry.
Extraction of genomic DNA from fermentation 
slurries
In a subset of 8 participants, 16S rRNA amplicon sequenc-
ing of the human gut microbiome and quantification of total 
and 5 dominant bacterial groups were performed. Samples 
were thawed at room temperature and after centrifugation at 
12,000 g for 5 min, genomic DNA from the resultant pellet 
was extracted using the DNeasy Powersoil Kit. The purity 
and concentration of extracted DNA was quantified using 
the NanoDrop™ 1000 and Qubit.
Quantification of dominant bacterial groups 
of the human gut microbiome
Quantitative PCR (qPCR) was performed using TaqMan™ 
chemistry and quantified against serial dilution of standards 
prepared from pure bacterial cultures as described previ-
ously [22]. Total bacteria and 5 different bacterial groups 
were targeted (Bacteroides/Prevotella, Bifidobacterium, 
Blautia coccoides, Clostridium leptum and E. coli) (Online 
Resource 2). The PCR reaction consisted of 7.5 µl Taqman™ 
gene expression master mix, 2.25 µl nuclease-free water, 
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0.5 µl bovine serum albumin, 1.5 µl forward primer (9 µM), 
1.5 µl reverse primer (9 µM) and 0.75 µl probe (2.5 µM). 
qPCR was performed in triplicates and averages calculated 
for replicates where Ct difference was less than 0.2 Ct.
Characterisation of global microbiome with 16S 
rRNA sequencing
Sequencing of the V4 region of the 16S rRNA gene was per-
formed on the MiSeq (Illumina, Essex, UK) platform using 
2 × 250 bp paired-end reads [23, 24].
Bioinformatics
To enable analysis of the gut microbiome, 97% operational 
taxonomic units (OTUs) were generated from the 16S rRNA 
sequences using an adaptation of the VSEARCH pipeline 
(https ://githu b.com/torog nes/vsear ch/wiki/VSEAR CH-pipel 
ine) [25]. Quality filtering was performed on the combined 
paired reads with a maximum allowed expected error rate of 
0.5 base pairs per read. Sequences longer than 275 bp and 
shorter than 225 bp were also filtered out. The next steps 
involved dereplication, removal of singleton sequences and 
preclustering at 98%. Chimeras were removed using the 
VSEARCH implementation of the UCHIME de-novo algo-
rithm followed by the UCHIME reference-based method in 
conjunction with the ’Gold’ ChimeraSlayer reference data-
set [26, 27]. Finally, OTUs were assigned by clustering the 
remaining sequences at 97% and taxonomically classified 
using a naive Bayesian classifier method implemented in the 
dada2 R package [28].
Statistical analysis
Data are presented as medians and interquartile (Q1–Q3) 
range. One-sample Wilcoxon (non-normally distributed 
data) or paired t test (normally distributed data) was used 
to calculate the difference between each additive and the 
control. Microbiome analysis using the 16S rRNA gene 
sequences was carried out in R version 3.5.3. The alpha 
diversity measures (i.e. rarefied richness, Chao1 richness 
estimate, Shannon diversity index, and Pielou’s evenness) 
were all calculated using the vegan package [29]. Permuta-
tion ANOVA results were also generated using vegan on 
both Bray–Curtis and UniFrac distance matrices. In the case 
of UniFrac the phylogenetic tree was generated using Fast-
Tree 2 [30]. Nonmetric multidimensional scaling (NMDS) 
was performed with the phyloseq package [31] and was used 
to visualise overall community structure in the form of ordi-
nation plots. Differentially abundant taxa were found using 
paired t-tests on log-relative abundances. Only significant 
differences greater than 0.5 logs are reported. Significance 
was set at 0.05.
Results
Effect of additives on net SCFA production
Figure  1 displays the net production of SCFA and 
Table 1 the median of the difference in their concen-
tration with respect to the 24 h control, for each addi-
tive. Fermentation of the control for 24 h increased the 
production of total SCFA (0 h vs 24 h; 1.73 vs 45.36, 
µmol/ml; p < 0.0001) (Fig.  1). Addition of maltodex-
trin and aspartame-based sweetener produced the high-
est median concentration of total SCFA whereas the 
dishwashing detergent the lowest (Fig.  1). Consider-
ing the individual SCFA, maltodextrin (p < 0.001) and 
aspartame-based sweetener (p < 0.001) increased the 
production of acetic acid whilst in contrast, dishwash-
ing detergent (p < 0.001) and sodium sulphite (p = 0.036) 
caused a significant decrease in acetic acid production 
compared with the control (Fig. 1). Production of propi-
onic acid was increased when maltodextrin (p = 0.014), 
polysorbate-80 (p = 0.044), sodium sulphite (p = 0.011) 
or the aspartame-based sweetener (p = 0.034) were pre-
sent (Fig. 1). Addition of cinnamaldehyde (p = 0.006) or 
dishwashing detergent (p = 0.012) significantly decreased 
the production of butyric acid when compared with the 
control; a similar non-significant effect (p = 0.052) was 
also observed for sodium sulphite (Fig. 1). Compared 
with the control, sucralose (p = 0.025) and polysorbate-80 
(p = 0.003) significantly increased production of valeric 
acid whereas when maltodextrin (p = 0.002), cinnamalde-
hyde (0.014), aspartame-based sweetener (p = 0.002) and 
the dishwashing detergent (p = 0.002) were added a sig-
nificant decrease was observed (Fig. 1). There was a sig-
nificant decrease in the production of caproic acid when 
maltodextrin (p = 0.012), cinnamaldehyde (p = 0.021), 
sodium sulphite (p = 0.014), aspartame-based sweetener 
(p = 0.002) or dishwashing detergent (p = 0.010) were 
added (Fig. 1). Caprylic acid significantly increased in 
the presence of maltodextrin (p = 0.006), polysorbate-80 
(p = 0.002), aspartame-based sweetener (p = 0.009) and 
dishwashing detergent (0.035) (Fig. 1). With regard to 
the BCFA, there was a significant decrease in the pro-
duction of isobutyric acid when maltodextrin (p = 0.002), 
cinnamaldehyde (p = 0.025), sodium butyrate (p = 0.014), 
aspartame-based sweetener (p < 0.001) or dishwash-
ing detergent (p = 0.002) were added (Fig. 1). Similar 
effects were also seen for isovaleric acid [maltodextrin 
(p = 0.002), cinnamaldehyde (p = 0.041), sodium benzoate 
(p = 0.004), aspartame-based sweetener (p < 0.001) and 
dishwashing detergent (p = 0.002)] (Fig. 1). Carboxym-
ethyl cellulose, toothpaste, carrageenan-kappa, titanium 
dioxide, sodium benzoate and stevia had no effect on the 
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production of any SCFA or BCFA. The effect of each 
of the substrates on the proportional ratio or SCFA are 
displayed in Online Resource 3.
Effect of additives on microbiome diversity indices
Compared to the control group, the addition of dishwash-
ing detergent significantly decreased all metrics of micro-
biome α-diversity, including OTU richness, evenness and 
the Shannon diversity index (Fig. 2). Incubation of faecal 
microbiota with cinnamaldehyde decreased the Shannon 
diversity index whereas an effect in the opposite direc-
tion was provoked by stevia. The effects of stevia and 
cinnamaldehyde on Shannon diversity index were due to 
an effect on microbiome community evenness rather than 
an impact on OTU richness (Fig. 2). There were no other 
significant effects on α-diversity indices for the rest of 
the substrates.
Effect of additives on microbiome community 
structure
Addition of sucralose, cinnamaldehyde, titanium diox-
ide, polysorbate-80 and dishwashing detergent induced 
significant shifts in microbiome community structure 
(β-diversity) using the Bray–Curtis dissimilarity index 
(Fig. 3). The most pronounced effects were from dish-
washing detergent followed by cinnamaldehyde, which 
explained 43.9% (p = 0.008) and 12.8% (p = 0.016) of the 
variance in microbiome community structure, respec-
tively. The effects of sucralose (R2 = 5.6%, p = 0.023), 
polysorbate-80 (R2 = 3.6%, p = 0.023) and titanium diox-
ide (R2 = 4.5%, p = 0.023) were significant but less pro-
nounced. When we looked at the effects of food additives, 
artificial sweeteners and domestic hygiene products on 
their microbiome community structure using UniFrac 
distances, which consider OTU phylogenetic relatedness, 
a significant effect was observed for cinnamaldehyde 
Fig. 1  Baseline and net production of total and individual short 
chain fatty acids (μmol/ml) following 24  h batch faecal fermenta-
tion of fibre with food additives, artificial sweeteners and domestic 
hygiene products. Red filling boxplot indicates significant difference 
(p < 0.05) compared with the CTRL (displayed with grey filling box-
plot); 0H baseline, CTRL control, SUCR sucralose, STEV stevia, ASP 
aspartame based sweetener, MDX maltodextrin, CNMD cinnamalde-
hyde, SS sodium sulphite, SB sodium benzoate, TIO titanium dioxide, 
CGN carrageenan-kappa, P80 polysorbate-80, CMC carboxymethyl 
cellulose, TP toothpaste, DET detergent
 European Journal of Nutrition
1 3
Ta
bl
e 
1 
 D
iff
er
en
ce
 (f
ro
m
 n
on
-a
dd
iti
ve
 co
nt
ro
l),
 in
 th
e n
et 
pr
od
uc
tio
n 
of
 to
tal
 an
d 
in
di
vi
du
al 
sh
or
t c
ha
in
 fa
tty
 ac
id
s (
μm
ol
/m
l) 
fo
llo
wi
ng
 2
4 
h 
ba
tch
 fa
ec
al 
fer
m
en
tat
io
n 
of
 fi
br
e w
ith
 fo
od
 ad
di
-
tiv
es
, a
rti
fic
ial
 sw
ee
ten
er
s a
nd
 do
m
es
tic
 hy
gi
en
e p
ro
du
cts
SC
FA
SU
CR
 
M
DX
ST
EV
CN
M
D
CM
C
P8
0
CG
N
SB
SS
TI
O
AS
P
TP
DE
T
To
ta
l S
C
FA
M
ed
ian
3.8
70
28
.46
0
2.4
50
− 
3.5
60
− 
2.4
60
1.3
90
2.0
10
− 
3.4
10
− 
2.2
40
0.7
10
30
.82
0
− 
0.7
00
− 
17
.01
0
Q1
− 
0.7
50
17
.75
0
− 
3.6
20
− 
8.8
80
− 
13
.78
0
− 
2.3
00
− 
0.7
20
− 
6.8
60
− 
5.7
50
− 
7.7
30
25
.73
0
− 
1.9
40
− 
19
.81
0
Q3
6.1
40
45
.07
0
8.9
40
7.8
40
9.8
50
5.4
00
6.6
50
2.1
00
2.3
70
3.1
60
40
.97
0
2.9
50
− 
13
.57
0
p v
alu
e
0.1
07
*
 <
 0.
00
1*
0.4
02
0.5
39
*
0.4
92
*
0.2
32
*
0.1
00
*
0.2
89
*
0.3
74
*
0.5
71
*
 <
 0.
00
1*
0.9
22
*
 <
 0.
00
1*
Ac
et
ic
 a
ci
d
M
ed
ian
2.3
00
29
.81
0
0.3
20
− 
0.3
60
− 
1.0
00
1.3
50
0.7
30
− 
1.1
60
− 
3.4
40
0.1
30
31
.55
0
− 
1.5
37
− 
10
.11
0
Q1
− 
0.6
20
16
.80
0
− 
3.9
90
− 
5.5
60
− 
8.8
90
− 
1.2
20
0.0
40
− 
4.0
70
− 
5.9
20
− 
1.8
80
23
.10
0
− 
2.5
00
− 
12
.57
0
Q3
4.7
20
44
.11
0
6.5
30
4.8
50
6.0
50
3.3
10
4.5
40
3.7
20
− 
0.2
80
2.3
80
40
.04
0
1.3
24
− 
7.4
60
p v
alu
e
0.0
81
*
 <
 0.
00
1*
0.6
25
0.9
19
*
0.5
81
*
0.2
19
*
0.0
70
*
0.4
75
*
0.0
36
*
0.7
83
*
 <
 0.
00
1*
0.1
04
*
 <
 0.
00
1*
Pr
op
io
ni
c 
ac
id
M
ed
ian
0.4
72
1.9
00
0.7
76
1.4
47
− 
0.4
27
0.2
57
− 
0.3
49
− 
0.8
73
1.7
60
− 
0.6
41
1.8
60
0.0
00
− 
2.6
10
Q1
− 
0.6
21
0.3
50
− 
0.0
52
− 
0.9
56
− 
3.1
42
− 
0.1
78
− 
0.9
97
− 
1.9
89
1.2
34
− 
3.0
19
0.9
40
− 
0.4
97
− 
5.4
00
Q3
1.1
16
4.3
80
1.3
80
2.8
70
1.2
41
1.0
57
1.6
39
0.4
01
5.9
10
0.3
97
3.5
00
0.6
78
0.9
00
p v
alu
e
0.3
64
0.0
14
0.2
77
*
0.4
37
*
0.6
65
*
0.0
44
*
0.8
89
*
0.2
18
*
0.0
11
*
0.2
35
0.0
34
*
0.8
49
*
0.0
71
*
Bu
ty
ri
c 
ac
id
M
ed
ian
0.6
47
− 
1.2
70
1.0
55
− 
1.9
59
− 
1.0
64
− 
0.6
37
0.9
58
0.1
38
− 
0.7
35
0.0
14
− 
1.2
40
1.2
37
− 
4.7
70
Q1
− 
0.3
25
− 
3.9
40
− 
0.8
69
− 
3.4
62
− 
2.6
08
− 
0.9
65
0.2
28
− 
2.0
55
− 
2.7
54
− 
2.1
96
− 
3.3
90
0.2
21
− 
6.5
40
Q3
1.1
97
4.7
40
1.2
85
− 
0.4
26
0.9
43
0.2
79
1.6
70
1.2
77
− 
0.0
92
0.4
47
1.5
90
2.8
87
− 
0.3
20
p v
alu
e
0.5
70
*
1.0
00
0.4
45
*
0.0
06
*
0.2
52
*
0.2
68
*
0.1
25
*
0.7
63
*
0.0
52
*
0.2
30
*
0.3
28
0.1
02
*
0.0
12
Va
le
ri
c 
ac
id
M
ed
ian
0.0
45
− 
0.6
55
0.0
11
− 
0.1
20
0.0
20
0.0
63
0.0
10
− 
0.0
18
− 
0.0
05
0.0
05
− 
0.6
69
0.0
67
− 
0.8
37
Q1
0.0
05
− 
0.7
85
− 
0.1
63
− 
0.0
50
− 
0.0
60
0.0
14
− 
0.0
50
− 
0.0
53
− 
0.1
26
− 
0.2
85
− 
0.7
86
− 
0.0
97
− 
0.9
56
Q3
0.1
86
− 
0.4
00
0.0
80
0.0
70
0.1
08
0.1
33
0.0
70
0.0
54
0.1
30
0.0
52
− 
0.4
45
0.1
15
− 
0.5
13
p v
alu
e
0.0
25
0.0
02
0.8
34
0.0
14
0.8
34
0.0
03
0.4
85
0.7
27
0.6
75
0.6
75
0.0
02
0.5
29
0.0
02
C
ap
ro
ic
 a
ci
d
M
ed
ian
0.0
01
− 
0.0
06
0.0
00
− 
0.0
02
− 
0.0
01
0.0
02
− 
0.0
01
− 
0.0
03
− 
0.0
05
− 
0.0
03
− 
0.0
07
0.0
01
− 
0.0
06
Q1
− 
0.0
04
− 
0.0
21
− 
0.0
04
− 
0.0
12
− 
0.0
13
− 
0.0
03
− 
0.0
07
− 
0.0
09
− 
0.0
16
− 
0.0
08
− 
0.0
19
− 
0.0
09
− 
0.0
21
Q3
0.0
06
− 
0.0
01
0.0
02
0.0
00
0.0
01
0.0
06
0.0
03
0.0
01
0.0
01
0.0
03
− 
0.0
05
0.0
03
− 
0.0
01
p v
alu
e
0.5
76
0.0
12
0.7
80
0.0
21
0.1
62
0.4
02
0.4
85
0.2
34
0.0
14
0.3
28
0.0
02
0.7
27
0.0
10
H
ep
ta
no
ic
 a
ci
d
M
ed
ian
0.0
04
0.0
00
0.0
01
0.0
00
0.0
00
0.0
04
0.0
00
0.0
09
− 
0.0
03
0.0
00
− 
0.0
05
0.0
00
− 
0.0
04
Q1
− 
0.0
05
− 
0.0
07
− 
0.0
05
− 
0.0
13
− 
0.0
11
− 
0.0
01
− 
0.0
07
0.0
01
0.0
09
− 
0.0
06
− 
0.0
12
− 
0.0
06
− 
0.0
09
Q3
0.0
18
0.0
05
0.0
08
0.0
10
0.0
02
0.0
09
0.0
02
0.0
12
0.0
00
0.0
02
0.0
00
0.0
06
0.0
08
p v
alu
e
0.3
07
0.8
13
0.6
25
0.7
56
0.4
76
0.4
65
0.9
06
0.1
42
0.1
07
0.4
07
0.2
21
1.0
00
0.6
89
European Journal of Nutrition 
1 3
Ta
bl
e 
1 
 (c
on
tin
ue
d)
SC
FA
SU
CR
 
M
DX
ST
EV
CN
M
D
CM
C
P8
0
CG
N
SB
SS
TI
O
AS
P
TP
DE
T
C
ap
ry
lic
 a
ci
d
M
ed
ian
0.0
00
0.0
22
0.0
00
0.0
00
0.0
00
0.0
11
0.0
00
0.0
00
0.0
00
0.0
00
0.0
33
0.0
00
0.0
00
Q1
0.0
00
0.0
02
0.0
00
0.0
00
0.0
00
0.0
07
0.0
00
0.0
00
0.0
00
0.0
00
0.0
00
0.0
00
0.0
00
Q3
0.0
09
0.1
47
0.0
02
0.0
00
0.0
00
0.0
14
0.0
00
0.0
00
0.0
00
0.0
00
0.1
65
0.0
00
0.0
15
p v
alu
e
0.1
42
0.0
06
0.2
01
0.5
84
1.0
00
0.0
02
0.3
61
1.0
00
0.4
23
0.3
71
0.0
09
0.5
84
0.0
35
Is
o 
bu
ty
ri
c 
ac
id
M
ed
ian
0.0
13
− 
0.2
93
− 
0.0
46
− 
0.0
76
− 
0.0
01
0.0
11
0.0
13
− 
0.1
04
− 
0.0
54
− 
0.0
05
− 
0.2
96
− 
0.0
12
− 
0.2
74
Q1
− 
0.0
57
− 
0.4
68
− 
0.1
70
− 
0.2
58
− 
0.0
89
− 
0.0
61
− 
0.0
78
− 
0.3
43
− 
0.1
74
− 
0.1
07
− 
0.4
72
− 
0.2
23
− 
0.4
87
Q3
0.0
46
− 
0.1
00
0.0
29
0.0
17
0.0
50
0.0
93
0.0
51
− 
0.0
63
0.0
35
0.0
11
− 
0.1
26
0.0
46
− 
0.1
13
p v
alu
e
0.3
75
*
0.0
02
0.1
63
*
0.0
25
0.9
44
0.7
80
0.8
70
*
0.0
14
*
0.1
84
0.2
11
*
 <
 0.
00
1*
0.3
43
*
0.0
02
Is
ov
al
er
ic
 a
ci
d
M
ed
ian
0.0
02
− 
0.4
61
− 
0.0
78
− 
0.1
26
0.0
47
0.0
19
− 
0.0
05
− 
0.2
20
− 
0.1
77
− 
0.0
19
− 
0.4
63
− 
0.0
37
− 
0.4
25
Q1
− 
0.0
38
− 
0.6
49
− 
0.1
25
− 
0.2
69
− 
0.0
15
− 
0.1
07
− 
0.1
19
− 
0.3
76
− 
0.0
18
− 
0.1
13
− 
0.6
45
− 
0.1
96
− 
0.6
42
Q3
0.1
24
− 
0.2
53
0.0
44
0.0
39
0.1
05
0.1
67
0.0
75
− 
0.1
15
0.0
72
0.0
32
− 
0.3
01
0.0
93
− 
0.2
60
p v
alu
e
0.2
08
*
0.0
02
0.4
87
*
0.0
41
*
0.8
95
*
0.7
59
*
0.6
75
0.0
04
*
0.2
66
*
0.3
38
*
 <
 0.
00
1*
0.6
14
*
0.0
02
Da
ta 
ar
e p
re
se
nt
ed
 as
 in
 µ
m
ol
/m
l o
f f
ae
ca
l s
lu
rry
; 1
-sa
m
pl
e W
ilc
ox
on
 te
st 
wa
s u
se
d 
fo
r n
on
-p
ar
am
etr
ic 
da
ta 
an
d 
a p
air
ed
 t-
tes
t f
or
 p
ar
am
etr
ic 
da
ta 
(in
di
ca
ted
 w
ith
 as
ter
isk
); 
wi
th
 b
ol
d 
fo
nt
s a
re
 
di
sp
lay
ed
 st
ati
sti
ca
lly
 si
gn
ifi
ca
nt
 di
ffe
re
nc
es
 (p
 <
 0.
05
)
SU
C
R  
su
cr
alo
se
, M
D
X 
m
alt
od
ex
tri
n, 
ST
EV
 st
ev
ia,
 C
N
M
D
 ci
nn
am
ald
eh
yd
e, 
C
M
C
 ca
rb
ox
ym
eth
yl
 ce
llu
lo
se
, P
80
 po
lys
or
ba
te 
80
, C
G
N
 ca
rra
ge
en
an
, S
B 
so
di
um
 be
nz
oa
te,
 SS
 so
di
um
 su
lp
hi
te,
 T
IO
 
tit
an
iu
m
 di
ox
id
e, 
AS
P 
as
pa
rta
m
e-
 ba
se
d s
we
ete
ne
r, 
TP
 to
ot
hp
as
te,
 D
ET
 de
ter
ge
nt
 European Journal of Nutrition
1 3
(R2 = 20.6%, p = 0.016) and dishwashing detergent 
(R2 = 63.4%, p = 0.008) (Fig. 4). The effect of dishwash-
ing liquid and cinnamaldehyde on microbiome commu-
nity structure dominated that of inter-subject variation 
(Figs. 3, 4).
Effect of additives on taxon relative abundance
In accordance with the significant shifts observed on α and 
β diversity, major effects in taxon relative abundance were 
observed with the fermentation of fibre in the presence of 
Fig. 2  Microbiome α-diversity indices before and following 24  h 
batch faecal fermentation of fibre with food additives, artificial 
sweeteners and domestic hygiene products. 0H baseline, CTRL con-
trol, SUCR sucralose, STEV stevia, ASP aspartame based sweetener, 
MDX maltodextrin, CNMD cinnamaldehyde, SS sodium sulphite, SB 
sodium benzoate, TIO titanium dioxide, CGN carrageenan-kappa, 
P80 polysorbate-80, CMC carboxymethyl cellulose, TP toothpaste, 
DET detergent
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cinnamaldehyde and dishwashing detergent (Fig. 5). Addi-
tion of dishwashing detergent increased the relative abun-
dance of OTU belonging to Escherichia/Shigella and Kleb-
siella and in parallel decreased the relative abundance of 33 
other OTUs, the majority of which belonged to Firmicutes. 
A similar increase of an OTU of Escherichia/Shigella was 
observed for cinnamaldehyde whereas 9 other OTUs, includ-
ing three of Faecalibacterium and four of Subdoligranulum, 
all important butyrate producers, significantly decreased 
(Fig. 5). The relative abundance of Escherichia/Shigella 
also increased in the presence of sucralose and carrageenan-
kappa. Similarly, a species of Bilophila increased with the 
addition of sucralose, sodium sulphite and polysorbate-80. 
Except for dishwashing detergent and cinnamaldehyde, 
major declines in the abundance of OTUs of Faecalibac-
terium and Subdoligranulum were observed using poly-
sorbate-80 as substrate. There was no effect on the addition 
of maltodextrin, stevia, titanium dioxide and toothpaste 
on OTU relative abundance (Fig. 5). Similar effects were 
observed at genus and at the family level (Online Resource 
4).
Effect of additives on the growth of major bacterial 
groups
Figure 6 shows the absolute concentration and Table 2 the 
median difference of 16S rRNA gene copy number, between 
the various additives and the control, for each bacterial 
group tested. Regardless of the type of additive tested, the 
concentration of total bacteria significantly increased after 
24 h fermentation and Bacteroides/Prevotella and C. leptum 
cluster typically represented the two most dominant groups 
(Fig. 6). Among the additives, the addition of carrageenan-
kappa (p = 0.034) and dishwashing detergent (p = 0.002), 
significantly decreased the concentration of total bacteria 
in comparison with the control group (Fig. 6). Similarly, 
maltodextrin (p = 0.021) and sodium benzoate (p < 0.001) 
significantly decreased the concentration of E. coli whereas 
addition of cinnamaldehyde (p = 0.014), sodium sulphite 
(p = 0.038) or dishwashing detergent (p < 0.001) promoted 
their growth (Fig. 6). The growth of species belonging to 
C. leptum significantly decreased in the presence of cinna-
maldehyde (p = 0.003), polysorbate-80 (p = 0.001), titanium 
dioxide (p = 0.029) and dishwashing detergent (p < 0.001) 
Fig. 3  Microbiome community structure (β diversity) using the 
Bray–Curtis dissimilarity index before and following 24 h batch fae-
cal fermentation of fibre with food additives, artificial sweeteners 
and domestic hygiene products. 0H baseline, CTRL control, SUCR 
sucralose, STEV stevia, ASP aspartame based sweetener, MDX malto-
dextrin, CNMD cinnamaldehyde, SS sodium sulphite, SB sodium 
benzoate, TIO titanium dioxide, CGN carrageenan-kappa, P80 poly-
sorbate-80, CMC carboxymethyl cellulose, TP toothpaste, DET deter-
gent
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and it was also the case for Bacteroides/Prevotella, when 
aspartame-based sweetener (p = 0.048) or dishwashing 
detergent were added (p = 0.001) (Fig. 6). Bifidobacte-
rium growth increased from the control with the addition 
of maltodextrin (p = 0.002), sodium benzoate (p = 0.008) 
and aspartame-based sweetener (p = 0.005) (Fig.  6). In 
contrast, a significant inhibitory effect on Bifidobacterium 
was observed with polysorbate-80 (p = 0.036), carrageenan-
kappa (p = 0.003), sodium sulphite (p = 0.013) or dishwash-
ing detergent (p < 0.001) (Fig. 6). When compared with the 
control group, cinnamaldehyde (p = 0.003), carrageenan-
kappa (p = 0.014), sodium sulphite (p = 0.001) and dish-
washing detergent (p = 0.014) significantly inhibited the 
growth of the B. coccoides group whereas maltodextrin 
(p = 0.002) and aspartame-based sweetener (p = 0.009) sig-
nificantly promoted this (Fig. 6). Stevia, sucralose, carboxy-
methyl cellulose and toothpaste had no significant effects 
on the growth of these broad bacterial populations (Fig. 6).
Discussion
It has become increasingly accepted that a diverse gut micro-
biome with high production of SCFA, particularly butyric 
acid, is an independent biomarker of host health. It is also 
known that diet influences the gut microbiome structure 
and function, including its fibre fermentation capacity [32]. 
However, relatively little is known about what effect that 
food additives, artificial sweeteners and accidental exposure 
to domestic hygiene products might have on the gut micro-
biome. As our diet has become more industrialised and is 
expected to become even more so to sustain food availability, 
it is important to understand the beneficial or detrimental 
effect food additives may have on the gut microbiome, and 
by extension to host health, to guide current and future use.
This study measured the effect of thirteen commonly 
used food additives, artificial sweeteners, and domestic 
hygiene products on the healthy gut microbiome compo-
sition and its fermentation capacity using in-vitro human 
microbiome batch fermentations. Changes in the ability of 
the gut microbiome to ferment fibre and produce SCFA and 
quantitative changes in major bacterial groups were meas-
ured and the summary results of this study are presented in 
Fig. 7. In addition to these analyses, the global microbiome 
Fig. 4  Microbiome community structure (β diversity) using the 
UniFrac unweighted distances before and following 24  h batch fae-
cal fermentation of fibre with food additives, artificial sweeteners 
and domestic hygiene products. 0H baseline, CTRL control, SUCR 
sucralose, STEV stevia, ASP aspartame based sweetener, MDX malto-
dextrin, CNMD cinnamaldehyde, SS sodium sulphite, SB sodium 
benzoate, TIO titanium dioxide, CGN carrageenan-kappa, P80 poly-
sorbate-80, CMC carboxymethyl cellulose, TP toothpaste, DET deter-
gent
▸
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Fig. 5  The effect of food addi-
tives, artificial sweeteners and 
domestic hygiene products 
on bacterial OTU relative 
abundance. 0H baseline, CTRL 
control, SUCR sucralose, STEV 
stevia, ASP aspartame based 
sweetener, MDX maltodextrin, 
CNMD cinnamaldehyde, SS 
sodium sulphite, SB sodium 
benzoate, TIO titanium dioxide, 
CGN carrageenan-kappa, P80 
polysorbate-80, CMC carboxy-
methyl cellulose, TP toothpaste, 
DET detergent, log2(FC) log2 
fold change
 European Journal of Nutrition
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composition and community structure were characterised 
using 16S rRNA gene amplicon sequencing as displayed in 
Fig. 8. Six of the additives affected the production of SCFA, 
five influenced the global microbiome community structure 
and nine altered the concentration of dominant microbial 
groups. Only toothpaste, stevia and carboxymethyl cellulose 
showed no or minimal effects on the broad composition and 
fermentation capacity of the faecal microbiome. However, 
for the additives for which an effect was observed, changes 
in microbiome composition and SCFA concentrations varied 
considerably among them; in terms of both the microorgan-
isms or SCFA affected as well as the direction of this effect. 
Thus, this study highlights that the gut microbiome is modi-
fiable in different ways by different additives. These vari-
able effects of various food additives also suggest that their 
impact on the gut microbiome needs to be studied separately 
for each, in combination with each other, and in addition to 
other macronutrients, micronutrients and fibre in our diet.
There is increasing interest in the effect of the food 
industrialisation on human health and particularly on 
non-communicable disease, such as inflammatory bowel dis-
ease and diabetes [10, 20]. In previous studies, these effects 
were associated directly or indirectly with the microbiome of 
the large bowel. A food additive can affect gut homeostasis 
by influencing either the gut microbiome, the mucus layer 
or both. Carrageenan-kappa, upon consumption, has been 
associated with an increased prevalence of intestinal lesions 
in animal models [33], highlighting a detrimental effect on 
the mucosal barrier. Recent evidence from experiments in 
mice shows that this effect may be mediated by changes in 
the abundance of Akkermansia muciniphila, a potent anti-
inflammatory bacterium. The results of the current study 
show that similar effects were observed with inhibition in 
the growth of Bifidobacterium and B. coccoides cluster, 
members of which have beneficial effects for the host [34]. 
Similarly, the dietary emulsifiers carboxymethyl cellulose 
and polysorbate-80 have been proposed to directly alter 
human microbiome composition and ex-vivo gene expres-
sion, potentiating intestinal inflammation [21]. Although 
in our current study no effect of carboxymethyl cellulose 
Fig. 6  Concentration of total and major bacterial groups (number 
of 16S rRNA gene copies/ml) before and following 24  h batch fae-
cal fermentation of fibre with food additives, artificial sweeteners and 
domestic hygiene products. Red filling boxplot indicates significant 
difference (p < 0.05) compared with the CTRL (displayed with grey 
filling boxplot); 0H baseline, CTRL control, SUCR sucralose, STEV 
stevia, ASP aspartame based sweetener, MDX maltodextrin, CNMD 
cinnamaldehyde, SS sodium sulphite, SB sodium benzoate, TIO tita-
nium dioxide, CGN carrageenan-kappa, P80 polysorbate-80, CMC 
carboxymethyl cellulose, TP toothpaste, DET detergent
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was seen on the fermentation capacity or on shifts in major 
bacterial groups, polysorbate-80 decreased the growth of 
Bifidobacterium and C. leptum and the relative abundance 
of other Firmicutes as confirmed by the results of both qPCR 
and 16S rRNA gene sequencing. Inorganic sulphite salts are 
frequently used to stop fermentation in wine and beer as well 
as antioxidants in food. This bacteriostatic effect of sodium 
sulphite was observed for members of the genus Bifidobac-
terium and the cluster B. coccoides and this effect may give 
a growth advantage to E. coli and Bilophila wadsworthia 
which gain energy through sulphite respiration [35]. Irwin 
et al. have previously described the bactericidal effects of 
sodium sulphite on probiotic-type bacteria, common mem-
bers of the human gut microbiome [36]. The exact opposite 
effects were observed for the growth of Bifidobacterium, 
the cluster B. coccoides and E. coli when either maltodex-
trin or the aspartame-based sweetener was present. This is 
likely to be because maltodextrin is an artificially produced 
glucose polymer which, if not absorbed in the small intes-
tine, has prebiotic properties in the colon [37]. Therefore, 
the increase in the probiotic genus Bifidobacterium and B. 
coccoides and the corresponding decrease in E. coli is most 
likely due to the fact that the former two use maltodextrin 
for growth [38, 39] instigating fermentation, production of 
acetic acid and creating an acidic environment in which E. 
coli growth is suppressed. Interestingly, changes in the abso-
lute concentration of these three dominant bacterial groups, 
quantified with qPCR, were not in parallel the absence of 
effects observed using next generation sequencing. Sodium 
benzoate has been shown to decrease plasma ammonium 
levels by reducing glycine metabolism to treat patients with 
urea-cycle-disorder and acute hyperammonaemia [40, 41]. 
Use of sodium benzoate in this study increased the beneficial 
Bifidobacterium but reduced E. coli and the concentration of 
BCFA, suggesting that protein fermentation and potentially 
production of ammonia from bacterial metabolism in the gut 
is diminished. Similar to maltodextrin, these effects were not 
observed with in-depth characterisation of the microbiome 
using 16S rRNA sequencing. However, discordant results 
are to be expected as qPCR provides an absolute quantifica-
tion of broader groups of bacteria and 16S rRNA sequencing 
offers proportional representation of the overall microbial 
community. The aspartame-based sweetener we used in this 
study was rich in maltodextrin in addition to, aspartame and 
Fig. 7  Heatmap illustrating 
the summary effects of food 
additives, artificial sweeten-
ers and domestic hygiene 
products on net production of 
total and individual short chain 
fatty acids and concentration 
of total and major bacterial 
groups. 0H baseline, CTRL 
control, SUCR sucralose, STEV 
stevia, ASP aspartame based 
sweetener, MDX maltodextrin, 
CNMD cinnamaldehyde, SS 
sodium sulphite, SB sodium 
benzoate, TIO titanium dioxide, 
CGN carrageenan-kappa, P80 
polysorbate-80, CMC carboxy-
methyl cellulose, TP toothpaste, 
DET detergent. Red indicates a 
decrease and green an increase 
in the concentration of short 
chain fatty acids or bacterial 
groups
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acesulflame potassium. This, therefore, prevented the study 
of aspartame in isolation. However, the absence of major dif-
ferences between the maltodextrin and the aspartame-based 
sweetener suggests that most of the effect seen on the gut 
microbiome comes from maltodextrin with no major contri-
butions of aspartame and acesulfame potassium; at least in 
the amount we tested in this experiment which equals 8% of 
the estimated daily intake which might carry-over to the gut.
Crohn’s disease has been characterised by a gut microbi-
ome with a reduced number of Firmicutes, such as species 
belonging to C. leptum, Bifidobacterium and Bacteroidetes 
and an increase in Proteobacteria, particularly E. coli strains 
with adherent and invasive properties [22, 24]. Interestingly, 
the addition of cinnamaldehyde, a cinnamon ingredient, or 
dishwashing detergent increased the E. coli and decreased 
the C. leptum and B. coccoides growth. A similar effect was 
also observed for polysorbate-80 with a diminished abun-
dance of butyrate-producing species and increase in a spe-
cies of Bilophila, a hydrogen sulphide producer implicated 
in colitis in IL-10 knockout mice [42]. Assuming that the 
gut microbial dysbiosis seen in patients with Crohn’s dis-
ease is a primary defect of the disease, and such species are 
implicated in disease pathogenesis, these findings suggest 
that consumption of cinnamon-containing food, polysorb-
ate-80 and accidental ingestion of residual detergent on 
crockery and utensils may exacerbate dysbiosis and influ-
ence disease outcomes. Dishwashing detergent contains sur-
factants, which lower the surface tension, potentially caus-
ing degradation of mucus layer and the mucosal barrier to 
break-down thus potentially affecting microbial composition 
Fig. 8  Heatmap illustrating 
the effects of food additives, 
artificial sweeteners and domes-
tic hygiene products on mean 
relative abundance of the top 50 
dominant bacterial OTUs across 
all samples. 0H baseline, CTRL 
control, SUCR sucralose, STEV 
stevia, ASP aspartame based 
sweetener, MDX maltodextrin, 
CNMD cinnamaldehyde, SS 
sodium sulphite, SB sodium 
benzoate, TIO titanium dioxide, 
CGN carrageenan-kappa, P80 
polysorbate-80, CMC carboxy-
methyl cellulose, TP toothpaste, 
DET detergent, OTU Opera-
tional Taxonomic Unit
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[43] particularly microbes which are adjacent to epithelial 
cells. Many Firmicutes like Faecalibacterium and Subdol-
igranulum are butyric acid-producing bacteria; hence the 
diminishing production of butyric acid here coincides with 
the decline in the concentration and abundance of these taxa 
with the addition of cinnamaldehyde, and dishwashing deter-
gent. Firmicutes constitute a large proportion of the bacteria 
in the human gut microbiome, therefore, a significant change 
to the composition and functionality found within this phy-
lum could, in theory, have detrimental consequences to the 
host. Butyric acid, for example, is the preferable energy sub-
strate for the colonocytes and regulates regulatory T cells 
which play an important role in cell-mediated immunity 
[44]. A similar effect on C. leptum was seen for polysorb-
ate-80 and a modest one for titanium dioxide. Collectively 
this evidence proposes that these additives could exacerbate 
the microbial dysbiosis seen in inflammatory bowel disease.
This study looked at the effect of food additives, artifi-
cial sweeteners and domestic hygiene products on the gut 
microbiome composition and fibre fermentation capacity in 
healthy human individuals, using batch fermentations with 
human faecal inoculum; thus, complementing previous 
research in animals. Although in the current study the SCFA 
and microbiome composition profile of the control, follow-
ing 24 h fermentation, are in accordance to those that occur 
in the human gut, batch fermentation is a snapshot and not 
an exact simulant of human gut physiology and its complex 
dynamics [45, 46]. This may explain some of the discrepan-
cies between the findings of this study and previous research 
[10]. Batch faecal fermentations do, however, provide cru-
cial preclinical data, under well-controlled experimental 
conditions. They enable exploration of various additives at 
the same time and the direct effect on the gut microbiome in 
isolation of the host effect; hence bridging the gap between 
animal research and human trials. The data generated from 
this study offer important insights on where future research 
on additives should be directed, using animal experiments 
and human randomised controlled trials. In our case, this 
may be relevant for cinnamaldehyde, polysorbate-80, sodium 
sulphite, sodium benzoate, sucralose and dishwashing deter-
gent but not for carboxymethyl cellulose, and stevia. While 
maltodextrin and the aspartame-based sweetener influenced 
the gut microbiome composition and production of SCFA, 
they did not induce dysbiosis and their effect might be con-
sidered favourable by inhibiting the growth of E. coli, thus 
promoting Bifidobacterium and correspondingly increasing 
the production of acetic acid and propionic acid. This bifi-
dogenic effect of maltodextrin, an artificial glucose poly-
mer has been observed previously too [47]. These findings 
are in contrast to evidence suggesting that maltodextrin 
induces dysbiosis promoting gut inflammation [10]. Such 
discrepancies might be explained by broad differences in the 
methodology applied among studies and the fact that in the 
current study we explored the effect of maltodextrin on the 
gut microbiome in isolation of the host and gut physiology. 
However, maltodextrin is the main source of carbohydrate 
in proprietary feeds used for the amelioration of gut inflam-
mation with exclusive enteral nutrition in active Crohn’s dis-
ease [48, 49]. This reproducible clinical evidence challenges 
our current perceptions on the role of maltodextrin on gut 
inflammation.
This study contributes to the limited knowledge on the 
effect of food additives, artificial sweeteners and domestic 
hygiene products on the human gut microbiome composi-
tion and fibre fermentation capacity. We have shown that the 
presence of certain additives changed the microbial compo-
sition, and this became similar to the gut microbiome seen 
in individuals with either inflammatory bowel disease or 
obesity. For other additives, their effects were counterin-
tuitive and opposite to animal research, implicating them 
in gut inflammation, and by proxy to human inflammatory 
bowel disease [10, 50]. This study underpins the importance 
of evaluating each additive separately and not grouped by 
their functional class. Here, we lay the groundwork for 
future research into individual additives on the gut micro-
biome composition and its fermentation capacity measured 
over a longer time period both in public health research and 
in the context of therapeutic interventions in patients with 
established dysbiosis, including patients with inflammatory 
bowel disease.
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